Noninvasive testing for liver disease

May 1, 2021 12:10pm ‐ May 1, 2021 1:00pm

Identification: 25.2


Immune Disease of the Liver: AIH, PBC, PSC

May 1, 2021 12:10pm ‐ May 1, 2021 1:00pm

Identification: 25.3

Learning Objectives:
  • Upon completion of this activity, participants will be able to decide on the best treatment approach for patients with AIH who fail to respond to standard of care
  • Upon completion of this activity, participants will be able to identify patients with PBC who are likely to progress despite receiving first line therapy with ursodeoxycholic acid
  • Upon completion of this activity, participants will be able to apply a valid surveillance strategy for hepatobiliary malignancies in patients with PSC

Updates in Liver Transplantation

May 1, 2021 12:10pm ‐ May 1, 2021 1:00pm

Identification: 25.4

Learning Objectives:
  • Upon completion of this activity, the participant will understand data on liver transplantation of patients with alcohol-associated hepatitis
  • Upon completion of this activity, the participant will be aware of data on liver transplantation of HCV + organs into HCV - recipients
  • Upon completion of this activity, the participant will understand strategies to expand the liver donor pool

Chicago Classification: Gospel or guide?

May 1, 2021 12:10pm ‐ May 1, 2021 1:00pm

Identification: 25.5

Learning Objectives:
  • Recognize clinical presentations where high resolution manometry provides diagnostic value
  • Distinguish major motility disorders that have specific therapeutic options
  • Identify alternate testing options when high resolution manometry is inconclusive

New medications for gastrointestinal motility disorders

May 1, 2021 12:10pm ‐ May 1, 2021 1:00pm

Identification: 25.6

Learning Objectives:
  • Differentiate between various gastrointestinal motility disorder
  • Use appropriate drugs for managing these diseases

Determining the right age and intervals to screen for colon cancer in high risk populations

May 1, 2021 12:10pm ‐ May 1, 2021 1:00pm

Identification: 25.7

Learning Objective:
  • Review the recommendations for colon cancer screening in indivduals with a family history of cancer

Management of Acute Recurrent Pancreatitis

May 1, 2021 12:10pm ‐ May 1, 2021 1:00pm

Identification: 25.8


Bariatric surgery versus bariatric endoscopy for weight loss

May 1, 2021 12:10pm ‐ May 1, 2021 1:00pm

Identification: 25.9

Learning Objectives:
  • Learn the indications for bariatric surgery and endoscopy
  • Learn the potential advantage of bariatric surgery and endoscopy
  • Explore the latest endoscopic device available.

Staying ahead of the curve on duodenoscope reprocessing: how to best avoid infections

May 1, 2021 12:10pm ‐ May 1, 2021 1:00pm

Identification: 25.95

Learning Objectives:
  • Describe the epidemiology of duodenoscope-related infections
  • Summarize the response and request from governing bodies
  • Discuss methods for enhanced reprocessing and summarize duodenoscope modifications designed to avoid infection transmission

Use of blood testing for choosing, assessing and monitoring biologics in IBD

May 1, 2021 12:10pm ‐ May 1, 2021 1:00pm

Identification: 25.96

Learning Objectives:
  • Identify laboratory testing needed prior to and after initiating a biologic to assess safety and efficacy
  • Identify when to use proactive and reactive therapeutic drug monitoring for biologics in IBD to improve efficacy and maintain efficacy
  • Interpret the meaning of biologic drug levels in the setting of proactive and reactive drug monitoring